Stay updated on Efficacy of Pexidartinib in TGCT Clinical Trial
Sign up to get notified when there's something new on the Efficacy of Pexidartinib in TGCT Clinical Trial page.

Latest updates to the Efficacy of Pexidartinib in TGCT Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe NIH banner announcing a website transition and related terminology updates is no longer displayed above the page.SummaryDifference1%

- Check16 days agoChange DetectedThe footer revision identifier changes from v3.7.2 to v3.8.0; the page continues to show a 403 Forbidden error rather than the study record.SummaryDifference0.2%

- Check23 days agoChange DetectedA site-wide NIH banner announces a transition in terminology from “Artificial Intelligence” to “Super Intelligence.” The clinical trial details remain inaccessible on the page.SummaryDifference1%

- Check30 days agoChange DetectedThe footer’s site revision label changed from v3.7.1 to v3.7.2 while the page remained a 403 error page.SummaryDifference0.2%

- Check37 days agoChange DetectedThe footer revision identifier changed from v3.7.0 to v3.7.1, while the page continued to display a 403 Forbidden error.SummaryDifference0.2%

- Check57 days agoChange DetectedThe page now displays a 403 Forbidden error, indicating restricted access to the study record. The header and footer remain visible, while the main content is replaced with an access-denied message.SummaryDifference18%

Stay in the know with updates to Efficacy of Pexidartinib in TGCT Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efficacy of Pexidartinib in TGCT Clinical Trial page.